Literature DB >> 25744723

Molecular portraits of epithelial, mesenchymal, and hybrid States in lung adenocarcinoma and their relevance to survival.

Mark J Schliekelman1, Ayumu Taguchi2, Jun Zhu3, Xudong Dai3, Jaime Rodriguez2, Muge Celiktas4, Qing Zhang1, Alice Chin1, Chee-Hong Wong1, Hong Wang4, Lisa McFerrin1, Suhaida A Selamat5, Chenchen Yang5, Evan M Kroh1, Kavita S Garg1, Carmen Behrens6, Adi F Gazdar7, Ite A Laird-Offringa5, Muneesh Tewari8, Ignacio I Wistuba2, Jean P Thiery9, Samir M Hanash10.   

Abstract

Epithelial-to-mesenchymal transition (EMT) is a key process associated with tumor progression and metastasis. To define molecular features associated with EMT states, we undertook an integrative approach combining mRNA, miRNA, DNA methylation, and proteomic profiles of 38 cell populations representative of the genomic heterogeneity in lung adenocarcinoma. The resulting data were integrated with functional profiles consisting of cell invasiveness, adhesion, and motility. A subset of cell lines that were readily defined as epithelial or mesenchymal based on their morphology and E-cadherin and vimentin expression elicited distinctive molecular signatures. Other cell populations displayed intermediate/hybrid states of EMT, with mixed epithelial and mesenchymal characteristics. A dominant proteomic feature of aggressive hybrid cell lines was upregulation of cytoskeletal and actin-binding proteins, a signature shared with mesenchymal cell lines. Cytoskeletal reorganization preceded loss of E-cadherin in epithelial cells in which EMT was induced by TGFβ. A set of transcripts corresponding to the mesenchymal protein signature enriched in cytoskeletal proteins was found to be predictive of survival in independent datasets of lung adenocarcinomas. Our findings point to an association between cytoskeletal and actin-binding proteins, a mesenchymal or hybrid EMT phenotype and invasive properties of lung adenocarcinomas. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25744723      PMCID: PMC4846295          DOI: 10.1158/0008-5472.CAN-14-2535

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  49 in total

Review 1.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

Authors:  Héctor Peinado; David Olmeda; Amparo Cano
Journal:  Nat Rev Cancer       Date:  2007-05-17       Impact factor: 60.716

Review 2.  Epithelial-mesenchymal transitions in development and disease.

Authors:  Jean Paul Thiery; Hervé Acloque; Ruby Y J Huang; M Angela Nieto
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

Review 3.  Molecular requirements for epithelial-mesenchymal transition during tumor progression.

Authors:  Margit A Huber; Norbert Kraut; Hartmut Beug
Journal:  Curr Opin Cell Biol       Date:  2005-10       Impact factor: 8.382

Review 4.  Epithelium-mesenchyme interconversion as example of epithelial plasticity.

Authors:  B Boyer; J P Thiery
Journal:  APMIS       Date:  1993-04       Impact factor: 3.205

5.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

6.  Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses.

Authors:  A Bhattacharjee; W G Richards; J Staunton; C Li; S Monti; P Vasa; C Ladd; J Beheshti; R Bueno; M Gillette; M Loda; G Weber; E J Mark; E S Lander; W Wong; B E Johnson; T R Golub; D J Sugarbaker; M Meyerson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-13       Impact factor: 11.205

Review 7.  The role of epithelial-mesenchymal transition in cancer pathology.

Authors:  Marcello Guarino; Barbara Rubino; Gianmario Ballabio
Journal:  Pathology       Date:  2007-06       Impact factor: 5.306

8.  Comparative secretome analysis of epithelial and mesenchymal subpopulations of head and neck squamous cell carcinoma identifies S100A4 as a potential therapeutic target.

Authors:  Kati Rasanen; Sira Sriswasdi; Alexander Valiga; Hsin-Yao Tang; Gao Zhang; Michela Perego; Rajasekharan Somasundaram; Ling Li; Kaye Speicher; Andres J Klein-Szanto; Devraj Basu; Anil K Rustgi; David W Speicher; Meenhard Herlyn
Journal:  Mol Cell Proteomics       Date:  2013-09-13       Impact factor: 5.911

9.  Epithelial-to-mesenchymal transition in the development and progression of adenocarcinoma and squamous cell carcinoma of the lung.

Authors:  Ludmila Prudkin; Diane D Liu; Natalie C Ozburn; Menghong Sun; Carmen Behrens; Ximing Tang; Kathlynn C Brown; B Nebiyou Bekele; Cesar Moran; Ignacio I Wistuba
Journal:  Mod Pathol       Date:  2009-03-06       Impact factor: 7.842

10.  The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity.

Authors:  K Aigner; B Dampier; L Descovich; M Mikula; A Sultan; M Schreiber; W Mikulits; T Brabletz; D Strand; P Obrist; W Sommergruber; N Schweifer; A Wernitznig; H Beug; R Foisner; A Eger
Journal:  Oncogene       Date:  2007-05-07       Impact factor: 9.867

View more
  87 in total

1.  How apoptosis and epithelial-to-mesenchymal transition are nested in EGFR inhibitors resistance in lung cancer.

Authors:  Simon Garinet; Audrey Didelot; Elena Garelli; Karine Pallier; Hélène Blons; Antoine Legras
Journal:  J Thorac Dis       Date:  2019-01       Impact factor: 2.895

2.  Immunoproteasome deficiency is a feature of non-small cell lung cancer with a mesenchymal phenotype and is associated with a poor outcome.

Authors:  Satyendra C Tripathi; Haley L Peters; Ayumu Taguchi; Hiroyuki Katayama; Hong Wang; Amin Momin; Mohit Kumar Jolly; Muge Celiktas; Jaime Rodriguez-Canales; Hui Liu; Carmen Behrens; Ignacio I Wistuba; Eshel Ben-Jacob; Herbert Levine; Jeffrey J Molldrem; Samir M Hanash; Edwin J Ostrin
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-29       Impact factor: 11.205

3.  ΔNp63α Promotes Breast Cancer Cell Motility through the Selective Activation of Components of the Epithelial-to-Mesenchymal Transition Program.

Authors:  Tuyen T Dang; Matthew A Esparza; Erin A Maine; Jill M Westcott; Gray W Pearson
Journal:  Cancer Res       Date:  2015-08-19       Impact factor: 12.701

4.  Survival Outcomes in Cancer Patients Predicted by a Partial EMT Gene Expression Scoring Metric.

Authors:  Jason T George; Mohit Kumar Jolly; Shengnan Xu; Jason A Somarelli; Herbert Levine
Journal:  Cancer Res       Date:  2017-09-25       Impact factor: 12.701

Review 5.  Epithelial-mesenchymal transition and inflammation at the site of the primary tumor.

Authors:  Charli Dominguez; Justin M David; Claudia Palena
Journal:  Semin Cancer Biol       Date:  2017-08-18       Impact factor: 15.707

6.  Hydrodynamic mobility of confined polymeric particles, vesicles, and cancer cells in a square microchannel.

Authors:  Shamim M Ahmmed; Naureen S Suteria; Valeria Garbin; Siva A Vanapalli
Journal:  Biomicrofluidics       Date:  2018-02-14       Impact factor: 2.800

7.  Testing the gene expression classification of the EMT spectrum.

Authors:  Dongya Jia; Jason T George; Satyendra C Tripathi; Deepali L Kundnani; Mingyang Lu; Samir M Hanash; José N Onuchic; Mohit Kumar Jolly; Herbert Levine
Journal:  Phys Biol       Date:  2019-01-18       Impact factor: 2.583

Review 8.  Epithelial-to-mesenchymal transition in tumor progression.

Authors:  Elena Prieto-García; C Vanesa Díaz-García; Inmaculada García-Ruiz; M Teresa Agulló-Ortuño
Journal:  Med Oncol       Date:  2017-05-30       Impact factor: 3.064

Review 9.  The pan-therapeutic resistance of disseminated tumor cells: Role of phenotypic plasticity and the metastatic microenvironment.

Authors:  Bo Ma; Alan Wells; Amanda M Clark
Journal:  Semin Cancer Biol       Date:  2019-07-31       Impact factor: 15.707

Review 10.  Emerging Biological Principles of Metastasis.

Authors:  Arthur W Lambert; Diwakar R Pattabiraman; Robert A Weinberg
Journal:  Cell       Date:  2017-02-09       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.